GOVERNMENT COUNSEL, LLC

Lobbying for APOTEX CORPORATION · Generic pharmaceutical manufacturer

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · Senate · $20,000.00 income · posted Oct 2, 2025

Lobbying activity 1

Manufacturing

Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.